# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-18-231700
Filing Date
2018-07-30
Accepted
2018-07-30 17:29:16
Documents
35
Period of Report
2018-07-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d592253d8k.htm | 8-K | 15951
2 | EX-99.1 | d592253dex991.htm | EX-99.1 | 35610
3 | GRAPHIC | g592253ex99_1s10g1.jpg | GRAPHIC | 308169
4 | GRAPHIC | g592253ex99_1s11g1.jpg | GRAPHIC | 67229
5 | GRAPHIC | g592253ex99_1s12g1.jpg | GRAPHIC | 390849
6 | GRAPHIC | g592253ex99_1s13g1.jpg | GRAPHIC | 275568
7 | GRAPHIC | g592253ex99_1s14g1.jpg | GRAPHIC | 418290
8 | GRAPHIC | g592253ex99_1s15g1.jpg | GRAPHIC | 332865
9 | GRAPHIC | g592253ex99_1s16g1.jpg | GRAPHIC | 252546
10 | GRAPHIC | g592253ex99_1s17g1.jpg | GRAPHIC | 297574
11 | GRAPHIC | g592253ex99_1s18g1.jpg | GRAPHIC | 422973
12 | GRAPHIC | g592253ex99_1s19g1.jpg | GRAPHIC | 388734
13 | GRAPHIC | g592253ex99_1s1g1.jpg | GRAPHIC | 527770
14 | GRAPHIC | g592253ex99_1s20g1.jpg | GRAPHIC | 193150
15 | GRAPHIC | g592253ex99_1s21g1.jpg | GRAPHIC | 335853
16 | GRAPHIC | g592253ex99_1s22g1.jpg | GRAPHIC | 283312
17 | GRAPHIC | g592253ex99_1s23g1.jpg | GRAPHIC | 339282
18 | GRAPHIC | g592253ex99_1s24g1.jpg | GRAPHIC | 391189
19 | GRAPHIC | g592253ex99_1s25g1.jpg | GRAPHIC | 257824
20 | GRAPHIC | g592253ex99_1s26g1.jpg | GRAPHIC | 76698
21 | GRAPHIC | g592253ex99_1s27g1.jpg | GRAPHIC | 327934
22 | GRAPHIC | g592253ex99_1s28g1.jpg | GRAPHIC | 253388
23 | GRAPHIC | g592253ex99_1s29g1.jpg | GRAPHIC | 304738
24 | GRAPHIC | g592253ex99_1s2g1.jpg | GRAPHIC | 601967
25 | GRAPHIC | g592253ex99_1s30g1.jpg | GRAPHIC | 262632
26 | GRAPHIC | g592253ex99_1s31g1.jpg | GRAPHIC | 183598
27 | GRAPHIC | g592253ex99_1s32g1.jpg | GRAPHIC | 354385
28 | GRAPHIC | g592253ex99_1s33g1.jpg | GRAPHIC | 525947
29 | GRAPHIC | g592253ex99_1s3g1.jpg | GRAPHIC | 86390
30 | GRAPHIC | g592253ex99_1s4g1.jpg | GRAPHIC | 247147
31 | GRAPHIC | g592253ex99_1s5g1.jpg | GRAPHIC | 380012
32 | GRAPHIC | g592253ex99_1s6g1.jpg | GRAPHIC | 52715
33 | GRAPHIC | g592253ex99_1s7g1.jpg | GRAPHIC | 279998
34 | GRAPHIC | g592253ex99_1s8g1.jpg | GRAPHIC | 311906
35 | GRAPHIC | g592253ex99_1s9g1.jpg | GRAPHIC | 252550
| Complete submission text file | 0001193125-18-231700.txt |  | 13808439

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 18978708
SIC: 2834 Pharmaceutical Preparations